重组
RabMAb

Anti-DNA PKcs (phospho S2056)抗体[EPR5670] (ab124918)

发表研究结果有使用 ab124918?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab124918 被引用在 4 文献中.

  • Lohse I  et al. Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts. PLoS One 11:e0167272 (2016). PubMed: 28033382
  • Hollingworth R  et al. Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. Viruses 7:2908-27 (2015). IF . PubMed: 26057167
  • Sowd GA  et al. SV40 utilizes ATM kinase activity to prevent non-homologous end joining of broken viral DNA replication products. PLoS Pathog 10:e1004536 (2014). PubMed: 25474690
  • Juvekar A  et al. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov 2:1048-63 (2012). WB ; Human . PubMed: 22915751

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册